Seoul Pharma Co. Ltd Net Asset Quality Index
Seoul Pharma Co. Ltd net asset quality index. Seoul Pharma Co. Ltd (018680) has a Net Asset Quality Index of 55.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩74.00 Billion minus total liabilities of ₩32.70 Billion yields net assets of ₩41.30 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Seoul Pharma Co. Ltd (018680) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Seoul Pharma Co. Ltd (2012–2024)
Net asset quality index of Seoul Pharma Co. Ltd from 2012 to 2024. This chart shows how Seoul Pharma Co. Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 55.8%, representing net assets of ₩41.30 Billion against total assets of ₩74.00 Billion KRW. Check 018680 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Seoul Pharma Co. Ltd Net Asset Quality Index by Year (2012–2024)
Seoul Pharma Co. Ltd net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Seoul Pharma Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 018680 market cap.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.1% | ₩40.17 Billion | ₩71.62 Billion | ₩31.45 Billion | ▼ -4.8 pp |
| 2023 | 60.9% | ₩38.56 Billion | ₩63.31 Billion | ₩24.74 Billion | ▲ +4.2 pp |
| 2022 | 56.7% | ₩35.42 Billion | ₩62.43 Billion | ₩27.01 Billion | ▲ +26.3 pp |
| 2021 | 30.5% | ₩18.96 Billion | ₩62.25 Billion | ₩43.29 Billion | ▼ -13.9 pp |
| 2020 | 44.3% | ₩28.85 Billion | ₩65.09 Billion | ₩36.23 Billion | ▲ +4.2 pp |
| 2019 | 40.1% | ₩28.45 Billion | ₩70.89 Billion | ₩42.44 Billion | ▼ -15.4 pp |
| 2018 | 55.6% | ₩50.31 Billion | ₩90.57 Billion | ₩40.25 Billion | ▼ -6.4 pp |
| 2017 | 62.0% | ₩53.86 Billion | ₩86.93 Billion | ₩33.08 Billion | ▲ +16.5 pp |
| 2016 | 45.5% | ₩42.07 Billion | ₩92.54 Billion | ₩50.47 Billion | ▲ +4.9 pp |
| 2015 | 40.6% | ₩33.53 Billion | ₩82.68 Billion | ₩49.15 Billion | ▲ +1.2 pp |
| 2014 | 39.4% | ₩31.10 Billion | ₩78.98 Billion | ₩47.88 Billion | ▼ -5.8 pp |
| 2013 | 45.2% | ₩32.25 Billion | ₩71.42 Billion | ₩39.17 Billion | ▲ +3.3 pp |
| 2012 | 41.8% | ₩25.38 Billion | ₩60.68 Billion | ₩35.29 Billion | — |